{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:03:53Z","timestamp":1781715833313,"version":"3.54.5"},"reference-count":40,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"name":"National Institute of Health\/National Institute of Diabetes and Digestive and Kidney Diseases","award":["R01 DK132406"],"award-info":[{"award-number":["R01 DK132406"]}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The primary objective of this study was to investigate whether ligand-receptor interactions (LRIs) between IGHG and FCGR gene products are associated with progression to type 1 diabetes (T1D). Using two completed clinical trials (DPT-1 and TN07), we applied next-generation targeted sequencing to genotype IGHG and FCGR genes in a cohort of 1,214 individuals and assessed LRI associations with disease progression. A Cox regression model was used to quantify LRI associations. IGHG or FCGR alone was found to have weak and sporadic associations with progression. Multiple LRIs between IGHG and FCGR gene products were found to be associated with progression, especially LRIs of IGHG2 with multiple FCGR receptors that accelerate progression and those of IGHG4 with multiple FCGR receptors (some overlapping) that delay progression. Furthermore, as several crystal structures of Fc\u03b3Rs complexed with distinct IgG molecules are known, application of this knowledge here was hampered by the absence of any information on the subclass distribution of each of the several T1D-related autoantibodies. It cannot be excluded that their respective state of glycosylation may influence binding affinity to various Fc\u03b3Rs and the function of thus-formed complexes. Our findings suggest that LRIs of the IGHG and FCGR gene products probably influence progression, shedding new insights into some of the immunological mechanisms involved in progression to T1D. Our findings potentially facilitate the search for new immunotherapeutic treatment through intervening at key steps in the progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                    <jats:p>This study investigated ligand-receptor interactions (LRIs) between IGHG and FCGR gene products in type 1 diabetes progression. Genes of 1,214 participants from the DPT-1 and TN07 trials were sequenced using next-generation targeted sequencing technology, and LRI associations with the progression time to type 1 diabetes were analyzed using Cox regression modeling. Weak associations were found for IGHG or FCGR variants individually, but multiple LRIs significantly impacted progression. Several IGHG2-FCGR interactions accelerated progression, while a few other IGHG4-FCGR interactions delayed it. The results may provide insights into certain immunogenetic mechanisms of T1D and suggest therapeutic potential of targeting specific LRIs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db25-0610","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T16:25:14Z","timestamp":1764779114000},"page":"379-388","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":2,"title":["Profiling Associations Between IGHG-FCGR Ligand-Receptor Interactions and Disease Progression From Stage 1 and 2 to Stage 3 Type 1 Diabetes"],"prefix":"10.2337","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4817-4969","authenticated-orcid":false,"given":"Lue Ping","family":"Zhao","sequence":"first","affiliation":[{"name":"Public Health Sciences Division, Fred Hutchinson Cancer Research Center 1 , Seattle, WA"},{"name":"School of Public Health, University of Washington 2 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George K.","family":"Papadopoulos","sequence":"additional","affiliation":[{"name":"Laboratory of Biophysics, Biochemistry, Biomaterials and Bioprocessing, Faculty of Agricultural Technology, Technological Educational Institute of Epirus 3 , Arta, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Skyler","sequence":"additional","affiliation":[{"name":"Diabetes Research Institute and Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine 4 , Miami, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemang M.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Health Informatics Institute, Morsani College of Medicine, University of South Florida 5 , Tampa, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Kwok","sequence":"additional","affiliation":[{"name":"Benaroya Research Institute 6 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry P.","family":"Lybrand","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Vanderbilt University 7 , Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Bondinas","sequence":"additional","affiliation":[{"name":"Department of Food Science and Technology, Faculty of Environmental Sciences, Ionian University 8 , Argostoli, Cephallonia, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis K.","family":"Moustakas","sequence":"additional","affiliation":[{"name":"Department of Food Science and Technology, Faculty of Environmental Sciences, Ionian University 8 , Argostoli, Cephallonia, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihan","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center 9 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Woo","family":"Pyo","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center 9 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyatt C.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center 9 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Geraghty","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center 9 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0499","authenticated-orcid":false,"given":"\u00c5ke","family":"Lernmark","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Lund University CRC, Sk\u00e5ne University Hospital 10 , Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"key":"2026061712173027300_B1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cct.2004.08.002","article-title":"SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth","volume":"25","author":"SEARCH Study Group","year":"2004","journal-title":"Control Clin Trials"},{"key":"2026061712173027300_B2","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2026061712173027300_B3","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.2337\/db07-1736","article-title":"Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1)","volume":"57","author":"Butty","year":"2008","journal-title":"Diabetes"},{"key":"2026061712173027300_B4","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.2337\/dc21-1628","article-title":"Association of HLA-DQ heterodimer residues \u221218\u03b2 and \u03b257 with progression from islet autoimmunity to diabetes in the Diabetes Prevention Trial-Type 1","volume":"47","author":"Zhao","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061712173027300_B5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2337\/dc23-1947","article-title":"HLA class II (DR, DQ, DP) genes were separately associated with the progression from seroconversion to onset of type 1 diabetes among participants in two Diabetes Prevention Trials (DPT-1 and TN07)","volume":"47","author":"Zhao","year":"2024","journal-title":"Diabetes Care"},{"key":"2026061712173027300_B6","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2337\/diab.44.6.608","article-title":"HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM","volume":"44","author":"Pugliese","year":"1995","journal-title":"Diabetes"},{"key":"2026061712173027300_B7","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc21-2612","article-title":"Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY Study","volume":"45","author":"Krischer","year":"2022","journal-title":"Diabetes Care"},{"key":"2026061712173027300_B8","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00125-025-06520-5","article-title":"Profiling associations of interactive ligand-receptors (HLA class I and KIR genes) with the progression to type 1 diabetes among seroconverted participants","volume":"68","author":"Zhao","year":"2025","journal-title":"Diabetologia"},{"key":"2026061712173027300_B9","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1172\/JCI130029","article-title":"Functional diversification of IgGs through Fc glycosylation","volume":"129","author":"Wang","year":"2019","journal-title":"J Clin Invest"},{"key":"2026061712173027300_B10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3389\/fimmu.2019.00811","article-title":"Understanding Fc receptor involvement in inflammatory diseases: from mechanisms to new therapeutic tools","volume":"10","author":"Ben Mkaddem","year":"2019","journal-title":"Front Immunol"},{"key":"2026061712173027300_B11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fc\u03b3 receptor function and the design of vaccination strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"2026061712173027300_B12","doi-asserted-by":"crossref","first-page":"100057","DOI":"10.1074\/jbc.REV120.013168","article-title":"Fc \u03b3 receptor compositional heterogeneity: considerations for immunotherapy development","volume":"296","author":"Barb","year":"2021","journal-title":"J Biol Chem"},{"key":"2026061712173027300_B13","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/genes14051028","article-title":"Deciphering the genetic code of autoimmune kidney diseases","volume":"14","author":"Huang","year":"2023","journal-title":"Genes (Basel)"},{"key":"2026061712173027300_B14","volume-title":"Janeway\u2019s Immunobiology.","author":"Murphy","year":"2017"},{"key":"2026061712173027300_B15","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.immuni.2024.06.009","article-title":"Antibody modulation of B cell responses-incorporating positive and negative feedback","volume":"57","author":"Cyster","year":"2024","journal-title":"Immunity"},{"key":"2026061712173027300_B16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.immuni.2024.10.002","article-title":"Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease","volume":"58","author":"Chakraborty","year":"2025","journal-title":"Immunity"},{"key":"2026061712173027300_B17","doi-asserted-by":"crossref","first-page":"1304365","DOI":"10.3389\/fimmu.2023.1304365","article-title":"Impact of structural modifications of IgG antibodies on effector functions","volume":"14","author":"Damelang","year":"2023","journal-title":"Front Immunol"},{"key":"2026061712173027300_B18","doi-asserted-by":"crossref","first-page":"113869","DOI":"10.1016\/j.celrep.2024.113869","article-title":"The follicular dendritic cell: at the germinal center of autoimmunity?","volume":"43","author":"Krimpenfort","year":"2024","journal-title":"Cell Rep"},{"key":"2026061712173027300_B19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa012350","article-title":"Effects of insulin in relatives of patients with type 1 diabetes mellitus","volume":"346","author":"Diabetes Prevention Trial\u2013Type 1 Diabetes Study Group","year":"2002","journal-title":"N Engl J Med"},{"key":"2026061712173027300_B20","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2017.17070","article-title":"Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: a randomized clinical trial","volume":"318","author":"Krischer","year":"2017","journal-title":"JAMA"},{"key":"2026061712173027300_B21","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00125-024-06274-6","article-title":"Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers","volume":"67","author":"Zhao","year":"2024","journal-title":"Diabetologia"},{"key":"2026061712173027300_B22","doi-asserted-by":"crossref","first-page":"e184348","DOI":"10.1172\/jci.insight.184348","article-title":"Two DRB3 residues predictively associate with the progression to type 1 diabetes among DR3 carriers","volume":"10","author":"Zhao","year":"2025","journal-title":"JCI Insight"},{"key":"2026061712173027300_B23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/antib11040065","article-title":"IMGT nomenclature of engineered IGHG variants involved in antibody effector properties and formats","volume":"11","author":"Lefranc","year":"2022","journal-title":"Antibodies (Basel)"},{"key":"2026061712173027300_B24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41586-020-2838-z","article-title":"Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection","volume":"588","author":"Bournazos","year":"2020","journal-title":"Nature"},{"key":"2026061712173027300_B25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.humimm.2015.05.001","article-title":"An integrated genotyping approach for HLA and other complex genetic systems","volume":"76","author":"Nelson","year":"2015","journal-title":"Hum Immunol"},{"key":"2026061712173027300_B26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/tan.13619","article-title":"Comparison of sequence-specific oligonucleotide probe vs next generation sequencing for HLA-A, B, C, DRB1, DRB3\/B4\/B5, DQA1, DQB1, DPA1, and DPB1 typing: toward single-pass high-resolution HLA typing in support of solid organ and hematopoietic cell transplant programs","volume":"94","author":"Smith","year":"2019","journal-title":"HLA"},{"key":"2026061712173027300_B27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4939-7868-7_4","article-title":"Genome-wide association studies","volume":"1793","author":"Dehghan","year":"2018","journal-title":"Methods Mol Biol"},{"key":"2026061712173027300_B28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/01621459.1987.10478410","article-title":"Better bootstrap confidence intervals","volume":"82","author":"Efron","year":"1987","journal-title":"JASA"},{"key":"2026061712173027300_B29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.2517-6161.1988.tb01731.x","article-title":"Bootstrap methods","volume":"50","author":"Hinkley","year":"1988","journal-title":"J R Statist Soc B"},{"key":"2026061712173027300_B30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey","year":"2002","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2026061712173027300_B31","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.1038\/ncomms7866","article-title":"Structural basis for binding of human IgG1 to its high-affinity human receptor Fc\u03b3RI","volume":"6","author":"Kiyoshi","year":"2015","journal-title":"Nat Commun"},{"key":"2026061712173027300_B32","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.3390\/ijms26051851","article-title":"A comprehensive review of Fc gamma receptors and their role in systemic lupus erythematosus","volume":"26","author":"Sepulveda-Delgado","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026061712173027300_B33","doi-asserted-by":"crossref","first-page":"104343","DOI":"10.1016\/j.ebiom.2022.104343","article-title":"Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity","volume":"86","author":"Robinson","year":"2022","journal-title":"EBioMedicine"},{"key":"2026061712173027300_B34","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/annrheumdis-2013-203565","article-title":"Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis","volume":"74","author":"Rombouts","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026061712173027300_B35","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.3390\/ijms21145017","article-title":"The role of IgG4 in the fine tuning of tolerance in IgE-mediated allergy and cancer","volume":"21","author":"Bianchini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026061712173027300_B36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41584-022-00867-4","article-title":"Glycobiology of rheumatic diseases","volume":"19","author":"Kissel","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"2026061712173027300_B37","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/biomedicines13051206","article-title":"Altered IgG N-glycosylation at onset of type 1 diabetes in children is predominantly driven by changes in the Fab N-glycans","volume":"13","author":"Plav\u0161a","year":"2025","journal-title":"Biomedicines"},{"key":"2026061712173027300_B38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imr.13407","article-title":"The importance of IgG glycosylation-what did we learn after analyzing over 100,000 individuals","volume":"328","author":"Kristic","year":"2024","journal-title":"Immunol Rev"},{"key":"2026061712173027300_B39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41568-023-00637-8","article-title":"Fc\u03b3 receptors and immunomodulatory antibodies in cancer","volume":"24","author":"Galvez-Cancino","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"2026061712173027300_B40","doi-asserted-by":"crossref","first-page":"926289","DOI":"10.3389\/fonc.2022.926289","article-title":"Relevance of Fc gamma receptor polymorphisms in cancer therapy with monoclonal antibodies","volume":"12","author":"Mata-Molanes","year":"2022","journal-title":"Front Oncol"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/2\/379\/848927\/db250610.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/75\/2\/379\/848927\/db250610.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T16:17:41Z","timestamp":1781713061000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/75\/2\/379\/163941\/Profiling-Associations-Between-IGHG-FCGR-Ligand"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,3]]},"published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db25-0610","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]}}}